CMMB news · CMMB stock

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Yahoo Finance · Oct 23, 2025 · Chemomab Therapeutics Ltd DRC (CMMB)

Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.